Why is Infinium Pharma falling/rising?

As of 05-Sep, Infinium Pharmachem Ltd is experiencing a decline in its stock price, currently at 250.00, which reflects a decrease of 4.7 or 1.85%. The stock has underperformed its sector by 1.78% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the delivery volume has significantly decreased by 47.37% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 0.99%, and it has seen a year-to-date drop of 16.64%, contrasting with a 4.64% increase in the benchmark index.
In the broader market context, the Sensex has shown a positive return of 1.29% over the past week, while Infinium Pharmachem Ltd's performance has been negative, highlighting a significant underperformance relative to the market. The stock's year-to-date decline of 16.64% starkly contrasts with the benchmark's positive return, suggesting that investor sentiment towards Infinium is weak compared to the overall market. This combination of poor short-term performance and declining investor interest contributes to the stock's current downward trend.